BACKGROUND
Elevated systolic blood pressure (SBP) is associated with paradoxically lower mortality in heart failure with reduced ejection fraction (HFrEF), but whether this reflects underlying pathophysiology or residual confounding remains uncertain. Because higher SBP is also a risk factor for kidney failure, we test...
H. Sheriff, Q. Zeng-Treitler, John G. F. Cleland et al.· American Journal of Medicine· 0 citations
Patiromer reduced serum potassium across baseline kidney function and hyperkalemia subgroups, with greater effect in patients with reduced kidney function and baseline hyperkalemia, which suggest potential heterogeneity in potassium-lowering effects of patiromer across subgroups.
A. Kalogeropoulos, A. M. Rashid, S. Anker et al.· Kidney360· 0 citations
Cancer therapy-related cardiovascular toxicity (CTR-CVT) remains a major contributor to morbidity and mortality among cancer survivors. While advances in cancer therapy have significantly improved survival rates, many of these treatments come at the cost of unintended cardiovascular damage. This creates a complex and...
Anaëlle Fratard, Georgia Kalogianni, N. Kindt et al.· European Heart Journal – Car...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.